Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Bevacizumab
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 100 mg/4 mL
- Dosage form
- Injection
- Pack
- 4ml vial
- Registration no.
- 127212
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-27 02:57
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (4ml vial). Current price PKR 17,674.07, effective 1 Jul 2025.
Cite this price history
MedInfoBase. Arketin 100 mg/4 mL, 4ml vial: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/arketin-100-mg-4-ml-127212-4ml-vial-ra-healthcare-smc-pvt-ltd/ (accessed 27 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 17,674.07 | 2025-07-01 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 127212Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
